Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer
- 1 July 1994
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 6 (1), 42-48
- https://doi.org/10.2165/00019053-199406010-00005
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as an Adjunct to Autologous Hemopoietic Stem Cell Transplantation for LymphomaAnnals of Internal Medicine, 1992
- Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.1991
- Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid CancerNew England Journal of Medicine, 1991
- Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.1991
- The impact of myeloid growth factors on engraftment following autologous bone marrow transplantation for malignant lymphoma.1991
- The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial.1991
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991
- GM-CSF ACCELERATES NEUTROPHIL RECOVERY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HODGKIN DISEASE1989
- Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) after bone marrow transplantation.1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988